Standard Follow-up Program Cervix Cancer (SFP CERVIX)

Cervical Cancer Radiation Complications Clinical Trial

— SFPCERVIX  

Official title:

Standard Follow-up Program Cervix Cancer (SFP CERVIX)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02733289
• Other study ID #: 201600207
• Status: Recruiting
• Start date: June 2015
• Est. completion date: December 2040

Study information

• Verified date: February 2024
• Source: University Medical Center Groningen
• Contact: Jannet Beukema
• Phone: +31503610025
• Email: j.c.beukema[@]umcg.nl
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 2040
• Est. primary completion date: December 2040
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Every cervical cancer patient with curative intent for radiotherapy, treated at our department

Exclusion Criteria:

• Non-curative treatment

• Part of the treatment is given in another hospital

Related Conditions & MeSH terms

• Cervical Cancer Radiation Complications
• Uterine Cervical Neoplasms

Locations

Country	Name	City	State
Netherlands	University Medical Center Groningen	Groningen

Sponsors (1)

Lead Sponsor	Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Complications	Physiological parameters, questionnaires	Five years